Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
This is a 14.3% decrease from the number of companies inspected in the previous quarter, when seven companies received seven inspections.
Most of the companies inspected at the time were involved in the Biologics sector. Both the Devices and Food and Cosmetics sectors sectors tied for second most common type.
All of the companies were in line with FDA regulations, and don't need to adjust their managing operations or regulatory/administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Advanced Integrated Motion | Devices | 12/12/2023 | No Action Indicated (NAI) |
BioLife Plasma Services LP | Biologics | 11/16/2023 | No Action Indicated (NAI) |
BioLife Plasma Services LP | Biologics | 10/26/2023 | No Action Indicated (NAI) |
Sports and Exhibition Authority of Pittsburgh and Allegheny County | Food and Cosmetics | 12/01/2023 | No Action Indicated (NAI) |
Vitalant | Biologics | 10/12/2023 | No Action Indicated (NAI) |
Vitalant | Biologics | 11/08/2023 | No Action Indicated (NAI) |